Automated devices significantly reduce the time and labour required to manually extract nucleic acids from the same number of samples. They also avoid the introduction of human error that can occur during manual extraction. The automated nucleic acid extraction devices are adaptable and efficient systems for fully automated nucleic acid isolation.
The global market for Automated Nucleic Acid Extraction Devices was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Automated Nucleic Acid Extraction Devices was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Automated Nucleic Acid Extraction Devices was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Automated Nucleic Acid Extraction Devices was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Automated Nucleic Acid Extraction Devices include QIAGEN, F. Hoffmann-La Roche Ltd, Analytik Jena GmbH+Co. KG, Thermo Fisher Scientific Inc, AccuBioMed Co., Ltd, AUTOGEN INC, Bioneer Corporation, Illumina, Inc. and Tecan Trading AG, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Automated Nucleic Acid Extraction Devices, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Automated Nucleic Acid Extraction Devices by region & country, by Type, and by Application.
The Automated Nucleic Acid Extraction Devices market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Automated Nucleic Acid Extraction Devices.
Market Segmentation
By Company
QIAGEN
F. Hoffmann-La Roche Ltd
Analytik Jena GmbH+Co. KG
Thermo Fisher Scientific Inc
AccuBioMed Co., Ltd
AUTOGEN INC
Bioneer Corporation
Illumina, Inc.
Tecan Trading AG
Merck KGaA
BD
PerkinElmer, Inc
DiaSorin SpA
TianLong Science and Technology Co., Ltd
Jiangsu Bioperfectus Technologies Co., Ltd
Zybio Inc
Hangzhou Bioer Technology
Daan Gene Co., Ltd
Sansure Biotech
BioTeke Corporation(wuxi) Co.,Ltd
Segment by Type:
Instruments
Kits
Segment by Application
Hospitals
CDC
Health Bureau
Maternal and Child Health Hospital
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Automated Nucleic Acid Extraction Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Automated Nucleic Acid Extraction Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Automated Nucleic Acid Extraction Devices in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Automated Nucleic Acid Extraction Devices Product Introduction
1.2 Global Automated Nucleic Acid Extraction Devices Market Size Forecast
1.2.1 Global Automated Nucleic Acid Extraction Devices Sales Value (2019-2030)
1.2.2 Global Automated Nucleic Acid Extraction Devices Sales Volume (2019-2030)
1.2.3 Global Automated Nucleic Acid Extraction Devices Sales Price (2019-2030)
1.3 Automated Nucleic Acid Extraction Devices Market Trends & Drivers
1.3.1 Automated Nucleic Acid Extraction Devices Industry Trends
1.3.2 Automated Nucleic Acid Extraction Devices Market Drivers & Opportunity
1.3.3 Automated Nucleic Acid Extraction Devices Market Challenges
1.3.4 Automated Nucleic Acid Extraction Devices Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Automated Nucleic Acid Extraction Devices Players Revenue Ranking (2023)
2.2 Global Automated Nucleic Acid Extraction Devices Revenue by Company (2019-2024)
2.3 Global Automated Nucleic Acid Extraction Devices Players Sales Volume Ranking (2023)
2.4 Global Automated Nucleic Acid Extraction Devices Sales Volume by Company Players (2019-2024)
2.5 Global Automated Nucleic Acid Extraction Devices Average Price by Company (2019-2024)
2.6 Key Manufacturers Automated Nucleic Acid Extraction Devices Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Automated Nucleic Acid Extraction Devices Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Automated Nucleic Acid Extraction Devices
2.9 Automated Nucleic Acid Extraction Devices Market Competitive Analysis
2.9.1 Automated Nucleic Acid Extraction Devices Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Automated Nucleic Acid Extraction Devices Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Automated Nucleic Acid Extraction Devices as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Instruments
3.1.2 Kits
3.2 Global Automated Nucleic Acid Extraction Devices Sales Value by Type
3.2.1 Global Automated Nucleic Acid Extraction Devices Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Automated Nucleic Acid Extraction Devices Sales Value, by Type (2019-2030)
3.2.3 Global Automated Nucleic Acid Extraction Devices Sales Value, by Type (%) (2019-2030)
3.3 Global Automated Nucleic Acid Extraction Devices Sales Volume by Type
3.3.1 Global Automated Nucleic Acid Extraction Devices Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Automated Nucleic Acid Extraction Devices Sales Volume, by Type (2019-2030)
3.3.3 Global Automated Nucleic Acid Extraction Devices Sales Volume, by Type (%) (2019-2030)
3.4 Global Automated Nucleic Acid Extraction Devices Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 CDC
4.1.3 Health Bureau
4.1.4 Maternal and Child Health Hospital
4.1.5 Other
4.2 Global Automated Nucleic Acid Extraction Devices Sales Value by Application
4.2.1 Global Automated Nucleic Acid Extraction Devices Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Automated Nucleic Acid Extraction Devices Sales Value, by Application (2019-2030)
4.2.3 Global Automated Nucleic Acid Extraction Devices Sales Value, by Application (%) (2019-2030)
4.3 Global Automated Nucleic Acid Extraction Devices Sales Volume by Application
4.3.1 Global Automated Nucleic Acid Extraction Devices Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Automated Nucleic Acid Extraction Devices Sales Volume, by Application (2019-2030)
4.3.3 Global Automated Nucleic Acid Extraction Devices Sales Volume, by Application (%) (2019-2030)
4.4 Global Automated Nucleic Acid Extraction Devices Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Automated Nucleic Acid Extraction Devices Sales Value by Region
5.1.1 Global Automated Nucleic Acid Extraction Devices Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Automated Nucleic Acid Extraction Devices Sales Value by Region (2019-2024)
5.1.3 Global Automated Nucleic Acid Extraction Devices Sales Value by Region (2025-2030)
5.1.4 Global Automated Nucleic Acid Extraction Devices Sales Value by Region (%), (2019-2030)
5.2 Global Automated Nucleic Acid Extraction Devices Sales Volume by Region
5.2.1 Global Automated Nucleic Acid Extraction Devices Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Automated Nucleic Acid Extraction Devices Sales Volume by Region (2019-2024)
5.2.3 Global Automated Nucleic Acid Extraction Devices Sales Volume by Region (2025-2030)
5.2.4 Global Automated Nucleic Acid Extraction Devices Sales Volume by Region (%), (2019-2030)
5.3 Global Automated Nucleic Acid Extraction Devices Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Automated Nucleic Acid Extraction Devices Sales Value, 2019-2030
5.4.2 North America Automated Nucleic Acid Extraction Devices Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Automated Nucleic Acid Extraction Devices Sales Value, 2019-2030
5.5.2 Europe Automated Nucleic Acid Extraction Devices Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Automated Nucleic Acid Extraction Devices Sales Value, 2019-2030
5.6.2 Asia Pacific Automated Nucleic Acid Extraction Devices Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Automated Nucleic Acid Extraction Devices Sales Value, 2019-2030
5.7.2 South America Automated Nucleic Acid Extraction Devices Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Automated Nucleic Acid Extraction Devices Sales Value, 2019-2030
5.8.2 Middle East & Africa Automated Nucleic Acid Extraction Devices Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Automated Nucleic Acid Extraction Devices Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Automated Nucleic Acid Extraction Devices Sales Value
6.2.1 Key Countries/Regions Automated Nucleic Acid Extraction Devices Sales Value, 2019-2030
6.2.2 Key Countries/Regions Automated Nucleic Acid Extraction Devices Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Automated Nucleic Acid Extraction Devices Sales Value, 2019-2030
6.3.2 United States Automated Nucleic Acid Extraction Devices Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Automated Nucleic Acid Extraction Devices Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Automated Nucleic Acid Extraction Devices Sales Value, 2019-2030
6.4.2 Europe Automated Nucleic Acid Extraction Devices Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Automated Nucleic Acid Extraction Devices Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Automated Nucleic Acid Extraction Devices Sales Value, 2019-2030
6.5.2 China Automated Nucleic Acid Extraction Devices Sales Value by Type (%), 2023 VS 2030
6.5.3 China Automated Nucleic Acid Extraction Devices Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Automated Nucleic Acid Extraction Devices Sales Value, 2019-2030
6.6.2 Japan Automated Nucleic Acid Extraction Devices Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Automated Nucleic Acid Extraction Devices Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Automated Nucleic Acid Extraction Devices Sales Value, 2019-2030
6.7.2 South Korea Automated Nucleic Acid Extraction Devices Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Automated Nucleic Acid Extraction Devices Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Automated Nucleic Acid Extraction Devices Sales Value, 2019-2030
6.8.2 Southeast Asia Automated Nucleic Acid Extraction Devices Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Automated Nucleic Acid Extraction Devices Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Automated Nucleic Acid Extraction Devices Sales Value, 2019-2030
6.9.2 India Automated Nucleic Acid Extraction Devices Sales Value by Type (%), 2023 VS 2030
6.9.3 India Automated Nucleic Acid Extraction Devices Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 QIAGEN
7.1.1 QIAGEN Company Information
7.1.2 QIAGEN Introduction and Business Overview
7.1.3 QIAGEN Automated Nucleic Acid Extraction Devices Sales, Revenue and Gross Margin (2019-2024)
7.1.4 QIAGEN Automated Nucleic Acid Extraction Devices Product Offerings
7.1.5 QIAGEN Recent Development
7.2 F. Hoffmann-La Roche Ltd
7.2.1 F. Hoffmann-La Roche Ltd Company Information
7.2.2 F. Hoffmann-La Roche Ltd Introduction and Business Overview
7.2.3 F. Hoffmann-La Roche Ltd Automated Nucleic Acid Extraction Devices Sales, Revenue and Gross Margin (2019-2024)
7.2.4 F. Hoffmann-La Roche Ltd Automated Nucleic Acid Extraction Devices Product Offerings
7.2.5 F. Hoffmann-La Roche Ltd Recent Development
7.3 Analytik Jena GmbH+Co. KG
7.3.1 Analytik Jena GmbH+Co. KG Company Information
7.3.2 Analytik Jena GmbH+Co. KG Introduction and Business Overview
7.3.3 Analytik Jena GmbH+Co. KG Automated Nucleic Acid Extraction Devices Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Analytik Jena GmbH+Co. KG Automated Nucleic Acid Extraction Devices Product Offerings
7.3.5 Analytik Jena GmbH+Co. KG Recent Development
7.4 Thermo Fisher Scientific Inc
7.4.1 Thermo Fisher Scientific Inc Company Information
7.4.2 Thermo Fisher Scientific Inc Introduction and Business Overview
7.4.3 Thermo Fisher Scientific Inc Automated Nucleic Acid Extraction Devices Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Thermo Fisher Scientific Inc Automated Nucleic Acid Extraction Devices Product Offerings
7.4.5 Thermo Fisher Scientific Inc Recent Development
7.5 AccuBioMed Co., Ltd
7.5.1 AccuBioMed Co., Ltd Company Information
7.5.2 AccuBioMed Co., Ltd Introduction and Business Overview
7.5.3 AccuBioMed Co., Ltd Automated Nucleic Acid Extraction Devices Sales, Revenue and Gross Margin (2019-2024)
7.5.4 AccuBioMed Co., Ltd Automated Nucleic Acid Extraction Devices Product Offerings
7.5.5 AccuBioMed Co., Ltd Recent Development
7.6 AUTOGEN INC
7.6.1 AUTOGEN INC Company Information
7.6.2 AUTOGEN INC Introduction and Business Overview
7.6.3 AUTOGEN INC Automated Nucleic Acid Extraction Devices Sales, Revenue and Gross Margin (2019-2024)
7.6.4 AUTOGEN INC Automated Nucleic Acid Extraction Devices Product Offerings
7.6.5 AUTOGEN INC Recent Development
7.7 Bioneer Corporation
7.7.1 Bioneer Corporation Company Information
7.7.2 Bioneer Corporation Introduction and Business Overview
7.7.3 Bioneer Corporation Automated Nucleic Acid Extraction Devices Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Bioneer Corporation Automated Nucleic Acid Extraction Devices Product Offerings
7.7.5 Bioneer Corporation Recent Development
7.8 Illumina, Inc.
7.8.1 Illumina, Inc. Company Information
7.8.2 Illumina, Inc. Introduction and Business Overview
7.8.3 Illumina, Inc. Automated Nucleic Acid Extraction Devices Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Illumina, Inc. Automated Nucleic Acid Extraction Devices Product Offerings
7.8.5 Illumina, Inc. Recent Development
7.9 Tecan Trading AG
7.9.1 Tecan Trading AG Company Information
7.9.2 Tecan Trading AG Introduction and Business Overview
7.9.3 Tecan Trading AG Automated Nucleic Acid Extraction Devices Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Tecan Trading AG Automated Nucleic Acid Extraction Devices Product Offerings
7.9.5 Tecan Trading AG Recent Development
7.10 Merck KGaA
7.10.1 Merck KGaA Company Information
7.10.2 Merck KGaA Introduction and Business Overview
7.10.3 Merck KGaA Automated Nucleic Acid Extraction Devices Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Merck KGaA Automated Nucleic Acid Extraction Devices Product Offerings
7.10.5 Merck KGaA Recent Development
7.11 BD
7.11.1 BD Company Information
7.11.2 BD Introduction and Business Overview
7.11.3 BD Automated Nucleic Acid Extraction Devices Sales, Revenue and Gross Margin (2019-2024)
7.11.4 BD Automated Nucleic Acid Extraction Devices Product Offerings
7.11.5 BD Recent Development
7.12 PerkinElmer, Inc
7.12.1 PerkinElmer, Inc Company Information
7.12.2 PerkinElmer, Inc Introduction and Business Overview
7.12.3 PerkinElmer, Inc Automated Nucleic Acid Extraction Devices Sales, Revenue and Gross Margin (2019-2024)
7.12.4 PerkinElmer, Inc Automated Nucleic Acid Extraction Devices Product Offerings
7.12.5 PerkinElmer, Inc Recent Development
7.13 DiaSorin SpA
7.13.1 DiaSorin SpA Company Information
7.13.2 DiaSorin SpA Introduction and Business Overview
7.13.3 DiaSorin SpA Automated Nucleic Acid Extraction Devices Sales, Revenue and Gross Margin (2019-2024)
7.13.4 DiaSorin SpA Automated Nucleic Acid Extraction Devices Product Offerings
7.13.5 DiaSorin SpA Recent Development
7.14 TianLong Science and Technology Co., Ltd
7.14.1 TianLong Science and Technology Co., Ltd Company Information
7.14.2 TianLong Science and Technology Co., Ltd Introduction and Business Overview
7.14.3 TianLong Science and Technology Co., Ltd Automated Nucleic Acid Extraction Devices Sales, Revenue and Gross Margin (2019-2024)
7.14.4 TianLong Science and Technology Co., Ltd Automated Nucleic Acid Extraction Devices Product Offerings
7.14.5 TianLong Science and Technology Co., Ltd Recent Development
7.15 Jiangsu Bioperfectus Technologies Co., Ltd
7.15.1 Jiangsu Bioperfectus Technologies Co., Ltd Company Information
7.15.2 Jiangsu Bioperfectus Technologies Co., Ltd Introduction and Business Overview
7.15.3 Jiangsu Bioperfectus Technologies Co., Ltd Automated Nucleic Acid Extraction Devices Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Jiangsu Bioperfectus Technologies Co., Ltd Automated Nucleic Acid Extraction Devices Product Offerings
7.15.5 Jiangsu Bioperfectus Technologies Co., Ltd Recent Development
7.16 Zybio Inc
7.16.1 Zybio Inc Company Information
7.16.2 Zybio Inc Introduction and Business Overview
7.16.3 Zybio Inc Automated Nucleic Acid Extraction Devices Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Zybio Inc Automated Nucleic Acid Extraction Devices Product Offerings
7.16.5 Zybio Inc Recent Development
7.17 Hangzhou Bioer Technology
7.17.1 Hangzhou Bioer Technology Company Information
7.17.2 Hangzhou Bioer Technology Introduction and Business Overview
7.17.3 Hangzhou Bioer Technology Automated Nucleic Acid Extraction Devices Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Hangzhou Bioer Technology Automated Nucleic Acid Extraction Devices Product Offerings
7.17.5 Hangzhou Bioer Technology Recent Development
7.18 Daan Gene Co., Ltd
7.18.1 Daan Gene Co., Ltd Company Information
7.18.2 Daan Gene Co., Ltd Introduction and Business Overview
7.18.3 Daan Gene Co., Ltd Automated Nucleic Acid Extraction Devices Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Daan Gene Co., Ltd Automated Nucleic Acid Extraction Devices Product Offerings
7.18.5 Daan Gene Co., Ltd Recent Development
7.19 Sansure Biotech
7.19.1 Sansure Biotech Company Information
7.19.2 Sansure Biotech Introduction and Business Overview
7.19.3 Sansure Biotech Automated Nucleic Acid Extraction Devices Sales, Revenue and Gross Margin (2019-2024)
7.19.4 Sansure Biotech Automated Nucleic Acid Extraction Devices Product Offerings
7.19.5 Sansure Biotech Recent Development
7.20 BioTeke Corporation(wuxi) Co.,Ltd
7.20.1 BioTeke Corporation(wuxi) Co.,Ltd Company Information
7.20.2 BioTeke Corporation(wuxi) Co.,Ltd Introduction and Business Overview
7.20.3 BioTeke Corporation(wuxi) Co.,Ltd Automated Nucleic Acid Extraction Devices Sales, Revenue and Gross Margin (2019-2024)
7.20.4 BioTeke Corporation(wuxi) Co.,Ltd Automated Nucleic Acid Extraction Devices Product Offerings
7.20.5 BioTeke Corporation(wuxi) Co.,Ltd Recent Development
8 Industry Chain Analysis
8.1 Automated Nucleic Acid Extraction Devices Industrial Chain
8.2 Automated Nucleic Acid Extraction Devices Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Automated Nucleic Acid Extraction Devices Sales Model
8.5.2 Sales Channel
8.5.3 Automated Nucleic Acid Extraction Devices Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
QIAGEN
F. Hoffmann-La Roche Ltd
Analytik Jena GmbH+Co. KG
Thermo Fisher Scientific Inc
AccuBioMed Co., Ltd
AUTOGEN INC
Bioneer Corporation
Illumina, Inc.
Tecan Trading AG
Merck KGaA
BD
PerkinElmer, Inc
DiaSorin SpA
TianLong Science and Technology Co., Ltd
Jiangsu Bioperfectus Technologies Co., Ltd
Zybio Inc
Hangzhou Bioer Technology
Daan Gene Co., Ltd
Sansure Biotech
BioTeke Corporation(wuxi) Co.,Ltd
听
听
*If Applicable.
